Microbot Medical Inc (MBOT)

[Cat dog]

MBOT Medical Robot much higher. Squeeze them but must have them in you portfolio you small cap stock that on the Nasdaq Accumulate I believe.

[Cat dog]

Tomorrow MBOT stays in the 3s a new foundation to climb to above 4 plus I believe. With news on there med robot about to be released I believe we will pass the 6 dollar mark I believe. MBOT !!! All out buy !!

[Cat dog]

MBOT-Shorts Scared short Squeeze incoming I believe !!! They will try anything. Squeeze them out !! Let’s get to @ 3 plus !!!

[Cat dog]

MBOT :: We are due for outstanding performance and news on the robot I believe

[Cat dog]

MBOT: Dr. Eyal Morag, Chief Medical Officer of Microbot Medical. “Lahey has performed countless human trials, and we believe its involvement, coupled with the performance of LIBERTY Robotic Surgical System during the animal studies, will be invaluable to our clinical advancements as we move into the next phases, including the Institutional Review Board (IRB) process.” MBOT

[subslover]

Thanks for the update. Much appreciated.

[TheFinalCD]

MBOT OFFERING CLOSED https://finance.yahoo.com/news/microbot-medical-announces-closing-1-163300910.html

[Cat dog]

MBOT conducting Human Factors and Usability Engineering tests of medical devices.The Robot !!

[Cat dog]

We have a new offering. Priced At-The-Market under Nasdaq Rules
HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 701,756 shares of the Company’s common stock at a purchase price of $2.1375 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered series C preferred investment options. The series C preferred investment options to purchase up to 350,878 shares of common stock have an exercise price of $2.075 per share and are immediately exercisable for a period of five and one-half years following issuance. The closing of the registered direct offering and the concurrent private placement is expected to occur on or about June 6, 2023, subject to the satisfaction of customary closing conditions.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offerings.

[The Night Stalker]

preclinical is testing on mice

[The Night Stalker]

preclinical is testing on mice

[Cat dog]

Close the shorts

[The Night Stalker]

nice

[Cat dog]

MBOT most in expensive stock in medical field I believe. New technology in this field is outstanding. Good Luck Peeps !!!

[wickerman]

$MBOT sometimes fluff news runs 200% you never know.

[Invest-in-America]

MBOT: In TRUTH, this was pure FLUFF "news" today, if there ever was such --- testing on MICE??? And to cap-off this typical 'MEDICAL-BREAKTHROUGH-OF-THE-DAY' crap routine, they toss-out yet more FLUFF news --- shortly before the Close today --- about dumping more SHARES onto the Market!!

THE BOTTOM LINE??? Who cares!!!??? Play THEM for the fools that they are, before they play US!!! MAKE THAT MONEY!!!

[retireat40]

Good lord you’re a clown

[TheFinalCD]

missed the window 3.40-2.80

[MT101]

$20+ in AH. Just announced 100% successful trial run.

[subslover]

All manipulated. There will be shares available to short. Keep looking. The volume today is from CDs and not part of the 16 million outstanding so those new shares need to clear.Let me know if you find anything to borrow tia

[Invest-in-America]

MBOT: WAS an easy one here today, Bro!! (Just gots-tah-know WHEN to dump 'em; right???)

[TheFinalCD]

BOUNCED TO 3.56

BUT
I COULDNT FIND SHARES TO BORROW

[Invest-in-America]

MBOT: See (below) latest, real-time, 'CHART' on this puppy, right now!! (Boy, glad I dumped this long ago today, for NICE profits!!)

[subslover]

They desperately need cash. Insiders took HUGE pay cuts. The pump today was perfectly orchestrated. The CD holders were dumped into the pump. Dirty work for sure but the Company can survive till the end of this year at least

[The Night Stalker]

beast mode

[The Night Stalker]

beast mode

[Invest-in-America]

MBOT: Whelp, glad I didn't get a 'PAY CUT' today behind this cute puppy!!

[TheFinalCD]

small offering @ the market...

LARGE SHELF
https://twitter.com/short_cap/status/1660728846524592130/photo/1

$MBOT
At 174Mil Volume for day and $MBOT only does 1.4$ Million offering, or 700k Shares??

Are they so nice?

— Ripster (@ripster47) May 22, 2023

[subslover]

Halted at $3.09

[TheFinalCD]

3.09 HALTED DOWN

[TheFinalCD]

PRICE PLUNGING NOW FROM

$MBOT [15s. delayed]: Issued Press Release on May 22, 15:18:00: Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules https://s.flashalert.me/1KyDY

NOT FROM THE LINK YOU PROVIDED

subslover

Member Level
Re: TheFinalCD post# 1005

Monday, May 22, 2023 2:43:27 PM

Post#
1006
of 1008
If you think that's nuts then your gonna love this that came out.https://www.otcmarkets.com/filing/html?id=16671743&guid=Zju-kKoIOwDaJth
Once the short sellers get noticed,we're looking at under $1.00

[subslover]

If you think that's nuts then your gonna love this that came out.https://www.otcmarkets.com/filing/html?id=16671743&guid=Zju-kKoIOwDaJth
Once the short sellers get noticed,we're looking at under $1.00

[TheFinalCD]

4.44

NUTZ

[Invest-in-America]

MBOT: HAAAA-HAAAAAAAAAAAAAAAAAAAAAAAA!!! (If ya don't play, ya can't WIN!!!)

[Triple nickle]

Mbot doctors in the study (paraphrased) sayin these ai bots are cool as shit look at em aren’t they cute doin what we do……
Wait wait wait a minute this things going to get me fired

[Invest-in-America]

MBOT: I'll be out at circa $10.00 --- a little LATER today.

[Invest-in-America]

MBOT: AI, Robotics, Cancer Cures, ChatSnap, Metaverse, China-Anything, inter alia --- just pull one out of a hat!!! (But FIRST consult with MY personal 'Broker', below!!)

[subslover]

Out at $3.00 bro.

[Triple nickle]

Yeah at 2.26

[Invest-in-America]

MBOT: And there it GOES!!! (Hope ya-all grabbed some earlier.)

Gonna be the OFFICIAL winner of this curious Markets day!!!

[Invest-in-America]

MBOT: Lookin' like it wants to SOAR from right here!!! (Peeps may simply like their AI & ROBOTICS gadets & stuff!!!)

[Invest-in-America]

MBOT: Me neither, Dude. (Cheap ANIMAL study; long way from anything HUMANS.)

HOWEVER!!! Since they gots lots of cute ROBOTICS stuff, well, maybe THAT's what's 'trending' on THIS particular day.

[TheFinalCD]

2.40'S

[Triple nickle]

Hmmmm not for me right now

[subslover]

MBOT
Microbot Medical Inc

Microbot Medical Inc (NASDAQ)
Search Symbol or Name

1.84
0.61 (49.59%)
Real-Time
Quote
Board
Chart
Level 2
News
Trades
OptionsNew
Financials
Public.com
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
May 22 2023 - 08:30AM
GlobeNewswire Inc.
Alert
Print
Share On Facebook

Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Surgical Robotic System, the first single-use endovascular robotic system, today announced a highly successful extended joint pre- clinical animal study held at a leading European-based research lab.
A team of six leading European interventional radiologists utilized the system and performed a total of 48 catheterizations to pre-determined vascular targets including distal branches of hepatic, gastric, splenic, mesenteric, renal, and hypogastric arteries, with a 100% success rate of reaching the intended target.

Based on real-time user feedback, the interventional radiologists found the system intuitive, easy to set up and use, and were impressed with the ability to control procedures remotely via the LIBERTY Robotic System’s remote controller.

“The results of the multi-day study continue to validate LIBERTY and is further evidence that the on-going adjustments we have made will ensure the safety and efficacy of the system as we plan to enter the human clinical phase during the second half of the year,” commented Dr. Eyal Morag, Chief Medical Officer.

“We believe this, along with other expected opportunities for peer-reviewed publications, will lay the foundation of showing the significant benefits LIBERTY is expected to bring when commercialized and helping to accelerate early adoption,” added Dr. Eyal Morag.

The Company plans on performing pre-clinical studies in the U.S. and other target markets, as well as first-in-human case in markets outside the U.S. in preparation for the continued progression toward commercialization of the LIBERTY Surgical Robotic System.

The 48 successful catheterizations are part of the Company’s recent announcement regarding surpassing 100th catheterization during multiple pre-clinical studies, with a 95% success rate of reaching pre-determined vascular targets.

About Microbot Medical

Microbot Medical Inc. (NASDAQ: MBOT) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, with the goals of improving clinical outcomes for patients and increasing accessibility through the natural and artificial lumens within the human body.
The LIBERTY Robotic System aims to improve the way surgical robotics are being used in endovascular procedures today, by eliminating the need for large, cumbersome, and expensive capital equipment, while reducing radiation exposure and physician strain. The Company believes the LIBERTY Robotic System’s remote operation has the potential to be the first system to democratize endovascular interventional procedures.
Further information about Microbot Medical is available at http://www.microbotmedical.com.

Safe Harbor

Statements to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as “will,” “believes,” “plans,” “anticipates,” “expects” and “estimates”) should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, market conditions, risks inherent in the development and/or commercialization of LIBERTY, the outcome of its studies to evaluate LIBERTY, whether the Company’s core business focus program and cost reduction plan are sufficient to enable the Company to continue to focus on its LIBERTY technology while it seeks additional working capital, any failure or inability to recruit physicians and clinicians to serve as primary investigators to conduct regulatory studies which could adversely affect or delay such studies, uncertainty in the results of pre-clinical and clinical trials or regulatory pathways and regulatory approvals, uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future capital, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical can be found under the heading “Risk Factors” in Microbot Medical’s periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC’s web site at www.sec.gov. Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Investor Contact:

Michal Efraty
[phone]
[e-mail]



Primary Logo

Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Apr 2023 to May 2023 Click Here for more Microbot Medical Charts. Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From May 2022 to May 2023 Click Here for more Microbot Medical Charts.
Latest MBOT Messages
redspinelpinktopaz Tue Dec 28, 2021 10:27 AM (509 days ago)
Probably lead to a financing?

Pt3 Mon Dec 27, 2021 1:44 PM (510 days ago)
seller beware lol

SteevoTrader Mon Dec 27, 2021 1:01 PM (510 days ago)
Agreed

Pedro2004 Mon Dec 27, 2021 11:34 AM (510 days ago)
*** Buyer Beware ***

Pedro2004 Mon Dec 27, 2021 11:33 AM (510 days ago)
Decided to take a loss on this today.

Pedro2004 Mon Dec 27, 2021 11:20 AM (510 days ago)
Shorts don't attack a company like this...unless the

Bigbruin Mon Dec 27, 2021 10:18 AM (510 days ago)
Wow

biglued1 Fri Jul 9, 2021 1:03 AM (682 days ago)
If you played MBOT right…..you’ve made a lot

ClayTrader Mon Aug 17, 2020 5:59 PM (1007 days ago)
* * $MBOT Video Chart 08-17-2020 * *

whytestocks Mon Aug 17, 2020 11:15 AM (1007 days ago)
News: $MBOT Microbot Medical Announces Successful Animal Study

See More Posts on MBOT Message Board
News
Press Releases
All News
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
GlobeNewswire Inc. • Mon May 22, 2023 8:30 AM (58 minutes ago)
Current Report Filing (8-k)
Edgar (US Regulatory) • Thu May 18, 2023 9:31 AM (4 days ago)
Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases
GlobeNewswire Inc. • Thu May 18, 2023 9:15 AM (4 days ago)
Quarterly Report (10-q)
Edgar (US Regulatory) • Wed May 17, 2023 5:01 PM (5 days ago)
Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
Edgar (US Regulatory) • Tue May 16, 2023 1:10 PM (6 days ago)
Current Report Filing (8-k)
Edgar (US Regulatory) • Mon May 08, 2023 8:30 AM (2 weeks ago)
Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System
GlobeNewswire Inc. • Mon May 08, 2023 8:30 AM (2 weeks ago)
Current Report Filing (8-k)
Edgar (US Regulatory) • Fri May 05, 2023 9:01 AM (2 weeks ago)
Microbot Medical Announces Final Data From Its Recent Animal Study
GlobeNewswire Inc. • Fri May 05, 2023 9:00 AM (2 weeks ago)
Current Report Filing (8-k)
Edgar (US Regulatory) • Wed May 03, 2023 9:01 AM (3 weeks ago)
Microbot Medical’s LIBERTY® Robotic System Surpasses 100th Catheterization
GlobeNewswire Inc. • Wed May 03, 2023 9:00 AM (3 weeks ago)
Current Report Filing (8-k)
Edgar (US Regulatory) • Thu Mar 23, 2023 9:01 AM (2 months ago)
More News Articles

Microbot Medical (NASDAQ:MBOT)
Intraday Stock Chart
Monday 22 May 2023

[redspinelpinktopaz]

Probably lead to a financing?

[Pt3]

seller beware lol

[SteevoTrader]

Agreed

[Pedro2004]

*** Buyer Beware ***

Dropped from $9.35 to $8.10 in a matter of minutes.

[Pedro2004]

Decided to take a loss on this today.